Sweep, a Montpellier, France carbon management platform, raised $73 million in Series B funding led by Coatue and was joined by investors including Balderton Capital, New Wave, La Famiglia, and 2050. division, raised $200 million in seed funding from investors including RRE Ventures, Foundation Capital, Original Capital, VanEck, Circle Ventures, Gaingels, and Gold House. Binance.US, the digital asset exchange and marketplace's U.S. Morgan, Sequoia Capital, Coatue, Lightspeed Venture Partners, and Lead Edge Capital. Grafana Labs, a New York-based performance monitoring platform developer, raised $240 million in Series D funding led by GIC and was joined by investors including J.P. Remote, a San Francisco-based HR management platform, raised $300 million in Series C funding led by SoftBank Vision Fund 2 and was joined by investors including Accel, Sequoia, Index Ventures, Two Sigma Ventures, General Catalyst, 9Yards, Adams Street, and Base Growth. Climeworks, a Zürich-based carbon removal technology company, raised $600 million CHF ($650 million) in funding led by Partners Group and GIC and was joined by investors including Baillie Gifford, Carbon Removal Partners, Global Founders Capital, John Doerr, M&G, Swiss Re ,and BigPoint Holding. While the conference is invite only, Term Sheet readers get special consideration. ![]() Join insightful leaders in health care, technology, and business to take a look at how new technologies, worldwide collaboration, evolving therapeutics, and big data drive better health outcomes and business value. Speaking of health tech… Fortune’s annual Brainstorm Health conference is just around the corner in Los Angeles. Shares of Frontier have fallen in price since the company announced the acquisition-making Frontier’s offer less appealing than it was only a few weeks ago. That’s the Spirit… JetBlue Airways has made an “unsolicited” offer for Spirit Airlines, a mere two months after Fontier agreed to buy its low-cost rival. The approval process for its new fund alone has taken the company a couple years.īut Donato says the company’s global reach and relationships with hospitals, pharmacies, and healthcare institutions will make it an attractive partner. One of the biggest challenges AmerisourceBergen will face is one any corporate giant wrestles with: speed. “One of the downsides of not being able to look at a broad set is you might get very excited about a particular solution or asset and not have a good enough sense of the competitive environment,” Donato says.īut venture capital is competitive, and it isn’t easy for any fund to stand out-not to mention a 42,000-employee healthcare services giant. Investing in startups will help AmerisourceBergen have a better sense of what new solutions and ideas are out there. The fund will be largely focused on early to middle stage investments, in the Series A and B rounds, says David Horowitz, co-founder and CEO of Touchdown Ventures. The company plans to make approximately two or three new investments a year, although there’s some flexibility in that number. The medical distribution company, which holds the #8 spot on the Fortune 500 list, has set aside $150 million, for now, and it is working with Touchdown Ventures, a third-party firm that manages corporate venture funds with T-Mobile, Kellogg’s, and others, to partner with entrepreneurs to bring new products to market.ĭonato says she sees investing that amount over “a few years,” noting that, should the company experience traction and meet their goals, AmerisourceBergen will likely set aside additional funding. More than two years later, AmerisourceBergen is finally ready to get on the cap table. “We didn’t have the capacity-the capacity and the people in-house-that were completely focused on that,” Donatao tells me, noting that the company has historically been more focused on M&A than it has minority investments. Now it wanted to parse through hundreds of investment opportunities a year and develop better insights into the market, says Leslie Donato, AmerisourceBergen’s executive vice president and Chief Strategy Officer. 2021, had previously made an occasional investment here and there. ![]() The company, which is one of the top pharmaceutical distributors in the world and posted nearly $214 billion in revenue in the year ending in Sep. ![]() ![]() Their sell: It was time for AmerisourceBergen to take a more hands-on approach to working with entrepreneurs and pharmaceutical testing.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |